Univest
Univest
  • Markets

Marico Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

  • June 25, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Marico Q1 Results

Marico Q1 Results FY27: Uniresearch projects Revenue Rs 3,595 Cr | PAT Rs 617 Cr (39-analyst consensus). Q4 FY26: Rev Rs 3,333 Cr | PAT Rs 408 Cr.

The Marico Q1 Results FY27 outlook is anchored on Q4 FY26 verified actuals and Uniresearch analysis applying the 39-analyst FY27 consensus to Q1 FY26 verified actuals. Uniresearch projects Revenue Rs 3,595 Cr (+10.3% YoY) and PAT Rs 617 Cr (+20.3% YoY). Prepared by Kunal Singla.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Marico Q1 Results FY27 – Uniresearch Prediction
  • Marico Q4 FY26 Key Metrics – Baseline for Marico Q1 Results FY27
  • What Analysts Are Saying About Marico
  • Key Watchpoints for Marico
    • Revenue Delivery vs Consensus for Marico
    • PAT Performance in Q1 Results FY27
  • Risks to the Marico Prediction
    • Below-Consensus Revenue Growth
    • PAT Pressure in Q1 Results FY27
  • Conclusion: Marico
  • Frequently Asked Questions on Marico
    • What is Uniresearch’s PAT prediction for Marico Q1 Results FY27?
    • What is the Revenue prediction for Marico Q1 Results FY27?
    • What were Marico Q1 Results FY27?
    • Does the Marico Q1 Results FY27?
    • What is the analyst target price mentioned in the Marico Q1 Results FY27?
    • What are the risks to the Marico Q1 Results FY27?
    • What is the Q1 FY26 base for the Marico Q1 Results FY27?

Marico Q1 Results FY27 – Uniresearch Prediction

Metric Q1 FY26 Actual Q1 Results FY27 Uniresearch Prediction YoY Change Source
Marico Revenue (Rs Cr) 3,259 3,595 +10.3% Uniresearch | 39-analyst consensus applied to Q1 FY26 verified actual
PAT (Rs Cr) 513 617 +20.3% Uniresearch | 39-analyst consensus applied to Q1 FY26 verified actual
Avg Analyst Target Rs 895 12-month view – Analyst consensus (39 analysts)

Predictions apply 39-analyst FY27 consensus (Rev +10.3%, PAT +20.3%) to Q1 FY26 verified actuals. Not guaranteed outcomes.

Marico Q4 FY26 Key Metrics – Baseline for Marico Q1 Results FY27

Metric Q4 FY26 Actual YoY Change Source
Revenue (Rs Cr) 3,333 +22.1% YoY Consolidated quarterly financial data
PAT (Rs Cr) 408 +18.3% YoY Consolidated quarterly financial data

What Analysts Are Saying About Marico

Across 39 analysts covering Marico, the FY27 consensus projects revenue growth of +10.3% and profit growth of +20.3%, with an average 12-month price target of Rs 895. The Q1 Results FY27 prediction reflects this consensus applied to verified Q1 FY26 actuals.

Key Watchpoints for Marico

Revenue Delivery vs Consensus for Marico

The primary watchpoint is whether Revenue in Q1 Results FY27 delivers in line with the Uniresearch projection of Rs 3,595 Cr (+10.3% consensus growth). Q1 FY26 base was Rs 3,259 Cr.

PAT Performance in Q1 Results FY27

The PAT watchpoint is whether Marico achieves Rs 617 Cr (+20.3% growth from Q1 FY26 base of Rs 513 Cr). Q4 FY26 PAT was Rs 408 Cr.

Risks to the Marico Prediction

Below-Consensus Revenue Growth

If Revenue comes in below the +10.3% consensus, actual revenue would fall short of Rs 3,595 Cr.

PAT Pressure in Q1 Results FY27

The PAT prediction of Rs 617 Cr could be impacted by cost escalation not factored into the 39-analyst consensus of +20.3%.

Conclusion: Marico

The Marico Uniresearch prediction of Revenue Rs 3,595 Cr and PAT Rs 617 Cr is derived from the 39-analyst consensus FY27 growth rates applied to verified Q1 FY26 actuals. When Q1 Results FY27 are declared, investors can benchmark actual performance against this consensus prediction. Track live updates on Univest.

Track Marico Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live Q1 Results FY27 alerts.

Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals – these are analyst consensus projections and are not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.

Frequently Asked Questions on Marico

What is Uniresearch’s PAT prediction for Marico Q1 Results FY27?

Ans. Uniresearch projects Marico Q1 Results PAT at Rs 617 Cr, applying 39-analyst FY27 profit growth consensus of +20.3% to Q1 FY26 verified PAT of Rs 513 Cr.

What is the Revenue prediction for Marico Q1 Results FY27?

Ans. Marico Q1 Results Revenue is projected at Rs 3,595 Cr, applying +10.3% FY27 revenue consensus to verified Q1 FY26 base.

What were Marico Q1 Results FY27?

Ans. Q4 FY26 consolidated Revenue was Rs 3,333 Cr (+22.1% YoY) and PAT was Rs 408 Cr (+18.3% YoY).

Does the Marico Q1 Results FY27?

Ans. No. All predictions in this article are derived from the 39-analyst consensus applied to verified Q1 FY26 actuals.

What is the analyst target price mentioned in the Marico Q1 Results FY27?

Ans. The 39-analyst consensus gives an average 12-month price target of Rs 895 for Marico.

What are the risks to the Marico Q1 Results FY27?

Ans. Risks include below-consensus revenue growth (target: +10.3%) and unexpected cost pressures impacting the +20.3% PAT consensus.

What is the Q1 FY26 base for the Marico Q1 Results FY27?

Ans. Q1 FY26 consolidated Revenue was Rs 3,259 Cr and PAT was Rs 513 Cr. These form the base for the Marico Q1 Results prediction.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply